Free Trial
CVE:VIV

Avivagen (VIV) Stock Price, News & Analysis

Avivagen logo
C$0.0050 0.00 (0.00%)
As of 03/5/2024

About Avivagen Stock (CVE:VIV)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.08
Volume
2,820 shs
Average Volume
49,827 shs
Market Capitalization
C$388,450.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Receive VIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

VIV Stock News Headlines

Avivagen Inc (VIV)
The most explosive assets in 2025?
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
Pure Harvest Corporate Group, Inc. (PHCG)
Closing Bell: Avivagen Inc flat on Monday (VIV)
Avivagen Announces New 500Kg Order for OxC-beta™
See More Headlines

VIV Stock Analysis - Frequently Asked Questions

Avivagen's stock was trading at C$0.01 on January 1st, 2025. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01.
View the best growth stocks for 2025 here
.

Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avivagen investors own include AtkinsRéalis (SNCAF) and ProMetic Life Sciences (PLI).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
Current Symbol
CVE:VIV
CIK
N/A
Fax
N/A
Employees
34,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.64 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$403,780.00
Cash Flow
C$0.00 per share
Price / Cash Flow
12.14
Book Value
C($0.12) per share
Price / Book
-0.04

Miscellaneous

Free Float
N/A
Market Cap
C$388,450.00
Optionable
Not Optionable
Beta
1.06
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (CVE:VIV) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners